Advertisement

Search Results for "piramal-pharma-solutions"

Forbes List Logo
Piramal Group demerges financial services, pharma businesses
Move seen to make valuations clearer; pharma company to be listed by mid-2022
BySalil Panchal
Q4'17: Robust growth in pharma and financial services helps Piramal Enterprises' net rise 61%
ByAveek Datta
Ajay Piramal: Investors Want a Decisive Government
ByAjay Piramal
Dilip Piramal: Time for more demonstrative action by the govt
ByDilip Piramal
The changing purpose and process of philanthropy: Aparna Piramal Raje
ByAparna Piramal Raje
Swati Piramal: How to Make India a World Leader in Low-Cost Health Care
BySwati Piramal
Vaccination key for economic recovery: Ajay Piramal
ByDivya J Shekhar
Anand Piramal invests undisclosed sum in Snapdeal
ByHarichandan Arakali
The Piramal family's purposeful philanthropy
BySalil Panchal
Why Realty Did Not Bite Piramal
BySamar Srivastava,Pravin Palande
Alkem Laboratories: From pharma distribution to a Rs 11,600 crore pharma major
ByNaini Thaker
FMCG Lessons for Pharma
ByISBInsight
Ajay Piramal announces launch of housing finance arm
BySalil Panchal
...

Latest News

Photo of the day: India Art Fair kicks off in Delhi
ByForbes India
RBI likely to hold interest rates in February 6 policy meet
BySalil Panchal
Economists flag upside to India growth after US tariff deal, but hold forecasts
BySamreen Wani
Why current tech stacks will fail DPDP (And what needs to change)
ByRoshmik Saha
Non-veg milk: The bone of contention in India-US trade deal
BySamidha Jain
Graphic of the day: Tariff relief cost: $2.5 trillion
BySamreen Wani
Why India’s IT giants are worried about Anthropic’s Claude Cowork
ByNaini Thaker
India’s concert economy: Booming sales, lagging infrastructure
ByNaini Thaker,Himani Kothari
AI agents form their own social network, humans left fascinated and alarmed
ByNaini Thaker
Advertisement
Advertisement

On Everyone’s Radar

Advertisement